CHIAN-SHONE CAPITAL Provides Initial US$20 Million Seed Fund For Biomedical Startups Represented By Ukraine, India, And Israel

CHIAN-SHONE CAPITAL, a financial capital company that is a VIE structure registered by Shanghai CHIAN-SHONE Asset Management Co, Ltd. plans to set up an initial US$20 million seed fund for startups in the biomedical industry which are represented by Ukraine, India, and Israel.

CHIAN-SHONE CAPITAL, a financial capital company that is a VIE structure registered by Shanghai CHIAN-SHONE Asset Management Co, Ltd. plans to set up an initial US$20 million seed fund for startups in the biomedical industry which are represented by Ukraine, India, and Israel.           

The company was supported by the domestic parent company Zhejiang Shenghuan Silk Co., Ltd which is referred as Shenghuan Shares which are based on the current era. Qifeng Zhao, who returned from the United States to take over as the president of Shenghuan Shares introduces foreign capital, expand the scale and transform the management methods and production under his leadership with new ideas.

The shift in the demand has divided through its original business philosophy about traditional single-operated high-end silk products. Based on retaining the original traditional crafts, they upgrade technology and develop active cross-border integration. The companies that are currently investing involve different industries such as tourism, silk finance, shale oil development, and bulk commodity trading.  

The establishment of CHIAN-SHONE CAPITAL was born in time. From its establishment, it already completed the VIE structure and matching of funds, from the start of the squatting and careful small investment to accumulate experience for more than two years. Henan Minxing Biotechnology Co., Ltd, (870227.OC) invested on it and listed on the National SME Share Transfer System on January 13, 2017, which has successfully exited.

With confidence and positive view of the bio-pharmaceutical industry in emerging market countries, CHIAN-SHONE CAPITAL engaged in a strategic cooperation agreement with the renowned venture capital fund of Kazakhstan, the KAUST INNOVATION FUND. The team-up us aimed to establish the first seed fund of 20 million US dollars that focus on The biomedical start-up individuals and teams in emerging market countries that are represented by Israel and Ukraine will offer financial support as well as follow-up financing services in mature markets.

Moreover, CEO Zhao Qifeng also hopes to implement the advantages and experience of mature US capital markets in finding investment institutions and investors having shared goals and values to support further and serve emerging market startups. 

Media Contact
Company Name: CHIAN-SHONE CAPITAL
Contact Person: Victor Zhao
Email: Send Email
Phone: (+1)918.884.7620
Address:215-217 9330 LBJ Freewy, Suite 900
City: Dallas
State: TX
Country: United States
Website: http://www.sp7silk.com/